CSIMarket
 


Pmv Pharmaceuticals Inc   (PMVP)
Other Ticker:  
 

Pmv Pharmaceuticals Inc 's Leverage Ratio

PMVP's quarterly Leverage Ratio and Total Liabilities, Equity growth




PMVP Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -19.62 % -18.02 % -16.21 % -14.08 % -11.93 %
Y / Y Total Liabilities Change 23.72 % 30.62 % 279.88 % 258.95 % 251.17 %
Leverage Ratio MRQ 0.09 0.09 0.08 0.07 0.06
Overall Ranking # # # # #
Seq. Equity Change -5.7 % -5.1 % -5.42 % -5.04 % -3.82 %
Seq. Total Liabilities Change 0.83 % 1.85 % 0.68 % 19.65 % 6.46 %



Leverage Ratio third quarter 2022 Comment
In Spite of the net new borrowings of 0.83% Pmv Pharmaceuticals Inc managed to improve Leverage Ratio in the third quarter 2022 to 0.09, above company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry Pmv Pharmaceuticals Inc achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are PMVP Customers?
Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #


Leverage Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Pmv Pharmaceuticals Inc 's Equity $ 261 Millions Visit PMVP's Balance sheet
Pmv Pharmaceuticals Inc 's Total Liabilities $ 24 Millions Visit PMVP's Balance sheet
Source of PMVP's Sales Visit PMVP's Sales by Geography


Cumulative Pmv Pharmaceuticals Inc 's Leverage Ratio

PMVP's Leverage Ratio for the trailling 12 Months

PMVP Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -19.62 % -18.02 % -16.21 % -14.08 % -11.93 %
Y / Y Total Liabilities TTM Growth 23.72 % 30.62 % 279.88 % 258.95 % 251.17 %
Leverage Ratio TTM 0.08 0.07 0.07 0.05 0.04
Total Ranking TTM # 76 # 188 # 152 # 63 # 72
Seq. Equity TTM Growth -5.7 % -5.1 % -5.42 % -5.04 % -3.82 %
Seq. Total Liabilities TTM Growth 0.83 % 1.85 % 0.68 % 19.65 % 6.46 %


TTM Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 0.83%, Leverage Ratio improved to 0.08, a new company high.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 34 other companies have achieved lower Leverage Ratio than Pmv Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. 76.

Explain Leverage Ratio?
Who are PMVP Customers?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 35
Healthcare Sector # 46
Within the Market # 76


TTM Leverage Ratio Statistics
High Average Low
0.08 0.05 0.02
(Sep 30 2022)   (Mar 31 2021)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity
Thorne Healthtech Inc   0.25 $ 32.963  Millions$ 131.923  Millions
Akouos inc   0.25 $ 44.671  Millions$ 180.838  Millions
Lftd Partners Inc   0.25 $ 8.365  Millions$ 33.934  Millions
Corvus Pharmaceuticals Inc   0.24 $ 15.667  Millions$ 64.681  Millions
Abcellera Biologics Inc   0.24 $ 302.237  Millions$ 1,250.172  Millions
Schrodinger Inc   0.24 $ 111.710  Millions$ 463.122  Millions
Longeveron Inc   0.24 $ 5.900  Millions$ 24.615  Millions
Benitec Biopharma Inc   0.24 $ 3.502  Millions$ 14.613  Millions
Zentalis Pharmaceuticals Inc   0.23 $ 100.689  Millions$ 428.738  Millions
Catalyst Pharmaceuticals Inc   0.23 $ 63.073  Millions$ 270.041  Millions
Regeneron Pharmaceuticals Inc   0.23 $ 4,911.700  Millions$ 21,438.800  Millions
Verve Therapeutics Inc   0.23 $ 125.412  Millions$ 547.943  Millions
Chinook Therapeutics Inc   0.23 $ 108.390  Millions$ 474.636  Millions
Ocuphire Pharma Inc   0.23 $ 2.691  Millions$ 11.877  Millions
Erasca Inc   0.22 $ 81.110  Millions$ 365.319  Millions
Angion Biomedica Corp  0.22 $ 11.106  Millions$ 50.210  Millions
Gain Therapeutics inc  0.22 $ 4.924  Millions$ 22.663  Millions
Vera Therapeutics Inc   0.22 $ 22.963  Millions$ 105.718  Millions
Matinas Biopharma Holdings Inc   0.22 $ 8.379  Millions$ 38.619  Millions
Kinnate Biopharma Inc   0.22 $ 53.792  Millions$ 248.341  Millions
Virpax Pharmaceuticals Inc   0.22 $ 4.208  Millions$ 19.428  Millions
Allakos Inc   0.22 $ 74.387  Millions$ 344.179  Millions
Amarin Corp Plcuk  0.21 $ 126.277  Millions$ 587.827  Millions
Aclaris Therapeutics Inc   0.21 $ 47.028  Millions$ 219.838  Millions
Geovax Labs Inc   0.21 $ 6.789  Millions$ 31.781  Millions
Vincerx Pharma Inc   0.21 $ 12.669  Millions$ 59.707  Millions
Sesen Bio Inc   0.21 $ 34.695  Millions$ 165.029  Millions
Ovid Therapeutics Inc   0.21 $ 29.713  Millions$ 142.051  Millions
Neximmune Inc   0.21 $ 9.959  Millions$ 47.716  Millions
Hcw Biologics Inc   0.21 $ 8.798  Millions$ 42.555  Millions

Date modified: 2022-11-10T15:51:36+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MCHX's Profile

Stock Price

MCHX's Financials

Business Description

Fundamentals

Charts & Quotes

MCHX's News

Suppliers

MCHX's Competitors

Customers & Markets

Economic Indicators

MCHX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071